{
  "trial_id": "NCT03321734",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Male and female infants born preterm at \u226430 weeks + 6 days post menstrual age",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Current treatment with routine caffeine",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "PMA 32 weeks + 0 days - 36 weeks + 6 days",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Anticipated last dose of routine caffeine will be by 36 weeks + 5 days",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "At least 12 hours of breathing room air with no ventilatory support other than on room air nasal air flow therapy regardless of flow rate, or on room air and receiving nasal CPAP, and relapse not anticipated.",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Able to tolerate enteral medications",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "It is feasible to administer the first dose of study drug no later than 36 weeks + 6 days PMA",
      "label": "met",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Intraventricular hemorrhage Grade III-IV or cystic periventricular leukomalacia",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Current or prior treatment for seizures",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Current or prior treatment for cardiac arrhythmias",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Known renal or hepatic dysfunction that in the opinion of the investigator would have a clinically relevant impact on caffeine metabolism",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Major malformation, inborn error of metabolism, chromosomal abnormality",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Presence of a condition for which survival to discharge unlikely",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has multiple comorbidities including COPD, OSA, obesity hypoventilation syndrome, dCHF. Daughter reports increased agitation and altered mental status x 2-3 days with O2 sats 60s-70s at home.",
  "_meta": {
    "topic_id": "14",
    "trial_id": "NCT03321734",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}